Analyzing Ratios: NovoCure Ltd (NVCR)’s Financial Story Unveiled

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of NovoCure Ltd (NASDAQ: NVCR) closed at $19.02 in the last session, up 1.98% from day before closing price of $18.65. In other words, the price has increased by $1.98 from its previous closing price. On the day, 1.17 million shares were traded. NVCR stock price reached its highest trading level at $19.36 during the session, while it also had its lowest trading level at $17.85.

Ratios:

We take a closer look at NVCR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.22 and its Current Ratio is at 6.46. In the meantime, Its Debt-to-Equity ratio is 1.87 whereas as Long-Term Debt/Eq ratio is at 1.87.

On August 28, 2023, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $85 to $25.

Piper Sandler Upgraded its Neutral to Overweight on August 08, 2023, while the target price for the stock was maintained at $45.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 04 ’24 when VERNON W ANTHONY sold 964 shares for $23.89 per share. The transaction valued at 23,033 led to the insider holds 164,833 shares of the business.

Scannell Timothy J sold 964 shares of NVCR for $23,027 on Jun 04 ’24. The Director now owns 2,964 shares after completing the transaction at $23.89 per share. On Jun 04 ’24, another insider, LEUNG GABRIEL, who serves as the Director of the company, sold 964 shares for $23.89 each. As a result, the insider received 23,025 and left with 78,175 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCR now has a Market Capitalization of 2058287360 and an Enterprise Value of 1782311680. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74 while its Price-to-Book (P/B) ratio in mrq is 5.68. Its current Enterprise Value per Revenue stands at 3.241 whereas that against EBITDA is -10.71.

Stock Price History:

Over the past 52 weeks, NVCR has reached a high of $41.51, while it has fallen to a 52-week low of $10.87. The 50-Day Moving Average of the stock is -4.79%, while the 200-Day Moving Average is calculated to be 22.88%.

Shares Statistics:

According to the various share statistics, NVCR traded on average about 1.50M shares per day over the past 3-months and 1083800 shares per day over the past 10 days. A total of 107.08M shares are outstanding, with a floating share count of 97.28M. Insiders hold about 10.11% of the company’s shares, while institutions hold 84.06% stake in the company. Shares short for NVCR as of 1721001600 were 7015439 with a Short Ratio of 4.69, compared to 1718323200 on 5585065. Therefore, it implies a Short% of Shares Outstanding of 7015439 and a Short% of Float of 7.8.

Most Popular